Nkarta
Utility Patents

Last updated:

List of all Nkarta patents 4 in total

Status Patent
Grant
Utility: Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy External link
Filling date: 7 Sep 2025 Issue date: 21 Jun 2022
Grant
Utility: CD19-directed chimeric antigen receptors and uses thereof in immunotherapy External link
Filling date: 7 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Cancer immunotherapy using CD19-directed chimeric antigen receptors External link
Filling date: 7 Sep 2025 Issue date: 26 Oct 2021
Grant
Utility: Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy External link
Filling date: 7 Sep 2025 Issue date: 12 Oct 2021

Showing 1 to 4 of 4 patents.